Avicanna Transitions US Listing to OTCQB
Financial Post ·
TORONTO, Oct. 16, 2026 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or “Company) (TSX: AVCN) (OTCQB: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based products announces that in the US, the Company will transition to OTCQB effective October 16, 2026. About Avicanna: Avicanna is an international biopharmaceutical company […]
SOURCE Avicanna Inc . Read More